does tirzepatide affect bone density Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes loss in obese mice via gut microbial-related metabolites GLP-1s and bone loss!

HR leaders should be prepared to address employee questions, evaluate plan coverage, communicate clearly about eligibility and costs, and consider supportive wellness strategies such as nutrition counselng, physical activity programs, and chronic disease prevention resources

Single hairs line the very front, temples are always filled in, and age-appropriate design matters

Practical Gastroenterology: Nutrition issues in Gastroenterology series #103: 2012 Chvanov M, Petersen O.H, Tepkin A

Our sample was largely white and female, further studies in more diverse populations are needed to examine sex and race differences